Key Developments: ResMed Inc (RMD.N)

RMD.N on New York Stock Exchange

48.38USD
1 Aug 2013
Price Change (% chg)

$0.73 (+1.53%)
Prev Close
$47.65
Open
$48.50
Day's High
$49.41
Day's Low
$47.90
Volume
522,336
Avg. Vol
238,662
52-wk High
$51.39
52-wk Low
$31.08

Search Stocks

Latest Key Developments (Source: Significant Developments)

ResMed Inc Declares Quarterly Dividend
Thursday, 1 Aug 2013 04:05pm EDT 

ResMed Inc announced that the Board of Directors has declared a quarterly dividend of $0.25 per share, which will have a record date of August 20, 2013, and be payable on September 17, 2013.  Full Article

ResMed Inc Succeeds in Patent Fight Against APEX Medical Corp
Thursday, 18 Jul 2013 08:45pm EDT 

ResMed Inc announced that a U.S. government investigation started at the request of ResMed against Taiwanese manufacturer APEX Medical Corp. has resulted in an administrative law judge at the International Trade Commission (ITC) determining that the ITC should enter a consent decree against APEX stopping the importation and sale of infringing APEX products. ResMed is a global innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions. The original action, filed by ResMed in March 2013 with the ITC, asserted patent infringement by two APEX masks and two APEX flow generators: the APEX WiZARD 210 and WiZARD 220 masks; and the APEX iCH and XT Fit flow generators. The ITC case against APEX also named Medical Depot, Inc., doing business as Drive Medical Design and Manufacturing (Drive). The same ITC administrative law judge previously determined that the ITC should enter a consent decree against Drive thereby ordering it to stop importation and sales of the Freedom 210 and Freedom 220 masks made by APEX, which are identical to the WiZARD masks.  Full Article

Resmed Inc Declares Quarterly Dividend
Thursday, 25 Apr 2013 04:05pm EDT 

Resmed Inc announced that it declared a quarterly dividend of $0.17 per share, which will have a record date of May 21, 2013, and be payable on June 18, 2013.  Full Article

Resmed Inc Files Lawsuit Against Apex Medical Corp
Wednesday, 3 Apr 2013 06:00am EDT 

Apex Medical Corp (Apex) announced that Resmed Inc filed a lawsuit against Apex in California Central District Court, alleging Apex's infringement of its patent right. Details were not disclosed.  Full Article

Resmed Inc Announces Changes In Board Of Directors
Wednesday, 20 Feb 2013 04:59pm EST 

Resmed Inc announced that effective March 1, 2013, Michael (Mick) Farrell will succeed Dr. Peter C. Farrell as ResMed's chief executive officer (CEO) and be appointed to its board of directors. Robert (Rob) Douglas will become ResMed's president and chief operating officer (COO). Current CEO, chairman of the board and founder, Dr. Farrell, will become executive chairman.  Full Article

Resmed Inc Declares Quarterly Dividend
Wednesday, 23 Jan 2013 07:00pm EST 

Resmed Inc announced that Board of Directors has declared a quarterly dividend of $0.17 per share, which will have a record date of February 19, 2013, and be payable on March 19, 2013.  Full Article

Resmed Inc Declares Quarterly Dividend
Thursday, 25 Oct 2012 04:08pm EDT 

Resmed Inc announced that the Board of Directors has today declared a quarterly dividend of $0.17 per share, which will have a record date of November 20, 2012, and be payable on December 18, 2012.  Full Article

ResMed Inc. Declares Quarterly Dividend
Thursday, 2 Aug 2012 04:13pm EDT 

ResMed Inc. announced that its Board of Directors have declared a quarterly dividend of $0.17 per share, which will have a record date of September 7, 2012, and be payable on September 28, 2012.  Full Article

ResMed Inc. Announces Holding Interest Of Perpetual Limited
Wednesday, 4 Jul 2012 02:20am EDT 

ResMed Inc. announced that Perpetual Limited has an interest of 78,850,607 ordinary shares, representing 5.07% of the voting power in the Company.  Full Article

ResMed Inc. Announces Holding Interest Of JCP Investment Partners Ltd
Wednesday, 2 Nov 2011 01:02am EDT 

ResMed Inc. announced that JCP Investment Partners Ltd is holding an interest of 78,431,898 ordinary shares, representing 5.04% of voting power in the Company.  Full Article

Search Stocks